“Globes” talks to leading figures in Israel’s cybersecurity industry to assess the threat posed by Anthropic’s new tool to detect vulnerabilities in code. IT

Former Bank Leumi chairman Samer Haj-Yehia, who served as advisor to Hapag-Lloyd, tells “Globes’ about the arduous and creative deal he brokered. Transport & infrastructure

Acting under the radar in the US, the Israeli company is revolutionizing orthopedic medicine and bone healing by introducing innovative fiber materials. Healthcare

Ali Ayoub told the Globes Putting the North at the Center Conference that Nvidia does not see the north as a periphery but as the center of the AI revolution. IT

Neri Oxman gives "Globes" a glimpse into how her company is channeling her vision into real-world transformations, on the small and large scale. Start ups

“Globes” calculates who earns what from the $32 billion acquisition of Wiz by Google and how much the Israel Tax Authority will receive. Mergers & acquisitions

People don't call in sick to extend their weekends, and parents of young children don't take more sick leave. So what is the main factor? Economy

Israeli venture capitalist Eden Shochat tells the ‘science fiction’ story and inspired bet behind the Israeli startup that has become Apple’s second biggest-ever acquisition. Mergers & acquisitions

As the control battle for the aesthetic medicine company heats up, co-founder and CEO Moshe Mizrahy blasts activist investors and backs the employees. Healthcare

Aviad Maizels has pulled off the unique trick of selling two companies to Apple but this time with much greater financial success. Mergers & acquisitions

To overcome the difficulties of holding Bitcoin in Israel, ZOOZ CEO Jordan Fried recommends buying his company’s stock. Market

The ambition of executing so many major projects all at once, headed by the Metro, is not matched by the availability of resources. Transport & infrastructure

“Globes” examines the urban development challenges facing small towns that will more than double in size in the coming years. Real estate

Or Yehuda-based Elsight is traded in Australia and has seen its share price soar 1,000% thanks to the surge in the drones market. IT

American-Iranian investor Amir Heshmatpour made his fortune in US biotech companies. He’s now in Israel with NeOnc, developer of a nasally administered brain cancer drug. Healthcare